Fundamental Data for HSP

Hospira Inc is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Their portfolio includes one of the industry''s broadest lines of generic acute-care injectables, integrated solutions for medication management and infusion therapy, and a full-service contract manufacturing business.

# Employees: 14500

Address: 275 North Field Drive,Lake Forest,IL,USA

Phone: 224-212-2000

Fax:

Website: www.hospira.com

Email: shareholder@computershare.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Christopher B. Begley (Chmn.; C.E.O.)

Thomas E. Werner (Sr. V.P. Fin.; C.F.O.)

Brian J. Smith (Sr. V.P.; Gen. Counl.; Sec.)

Edward A. Ogunro (Sr. V.P.; Research and Develot.; Chief Scientific)

Richard J. Hoffman (V.P.; Corp. Contrl. & Chief Acctg. Off.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/16/2010

Mean EPS (Next Qtr): $0.72

Mean EPS (Year): $2.93

Mean Estimate(Long Term): $12.42

P/E Ratio(Based on EPS estimate): 16.000

Number of Estimates: 6

Shares Performance

Period	HSP	Compare to S&P
YTD	74.79 %	44.66 %
4 Weeks	1.98 %	0.88 %
12 Weeks	18.53 %	11.75 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1052580

Shares Outstanding: 161M

Market Cap: $7.55B

52 Week High: $48.15

52 Week Low: $21.38

P/E Ratio: 15.570

PEG Ratio: 1.290

Split: On 1/1/1990 HSP split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: 23.29 %

EPS Growth in Last Year: 42.86 %

Sales Growth in Last Quarter: 5.29 %

Sales Growth in Last Quarter: 8.86 %

Financials

Qtr Book Value: $3.09

Cash Flow/Share: $11.35

Change in Payout Ratio: 0.000

Price/Sales: 2.020